Plain-English translation of NCT06907342 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new approach called functional precision medicine to help doctors choose the right chemotherapy for patients with advanced colon cancer that cannot be cured with surgery. Researchers will take a small sample of your tumor, grow it in the laboratory, and test how it responds to two different chemotherapy options: . The goal is to see if this laboratory test can help pick the treatment most likely to work for your specific tumor.
Currently, doctors choose between two standard chemotherapy options for advanced colon cancer based on general guidelines, but these drugs don't work equally well for every patient. This trial is testing whether a personalized laboratory test could help identify which medication will be most effective for your individual tumor, potentially leading to better results and fewer unnecessary side effects.
You likely qualify if…
You likely don't qualify if…
If you join this trial, your doctor will take a small tissue sample from your tumor through a needle biopsy. This sample will be sent to the laboratory where researchers will grow it and test how it responds to two different chemotherapy options. Based on the lab results, your doctor will recommend the chemotherapy that appears most likely to work for your tumor. You will then receive your personalized chemotherapy treatment as you normally would, and the research team will monitor how well the treatment works and track any side effects you experience.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Norway